How much funding has Calder Biosciences raised?

Calder Biosciences has raised $275K in total funding, most recently a Venture Round.

Who are Calder Biosciences's investors?

Calder Biosciences's investors include SOSV, IndieBio.

When was Calder Biosciences founded?

Calder Biosciences was founded in 2018.

Where is Calder Biosciences headquartered?

Calder Biosciences is headquartered in New York, New York, United States.

What industry is Calder Biosciences in?

Calder Biosciences operates in Biotech, Healthcare.

How many employees does Calder Biosciences have?

Calder Biosciences has 1-10 employees.

Calder Biosciences

Improving & Saving Lives with next-generation subunit vaccines

New York, United States · Founded 2018 · $275K raised

Biotech

Healthcare

Headquarters: New York, New York
Employees: 1–10
Founded: 2018
Business Model: B2B

Website: calderbiosciences.com
Total Funding: $275K
Last Round: $275K Venture RoundMay 2025
Rounds: 1

About

Calder Biosciences, Inc. is a nano-scale molecular engineering company applying its 3D-Vaxlock™ platform technology to develop conformationally stabilized prefusion subunit vaccines against RSV, universal influenza, and other viral pathogens. The company engineers site-specific, covalent crosslinks into proteins to lock immunogens in their most potent 3D shape, eliciting highly protective immune responses.

Summary

Calder Biosciences is a Biotech company based in New York, United States, founded in 2018. It has raised $275K in total across 1 round, most recently a $275K Venture Round round in May 2025. Investors include SOSV and IndieBio.